Search Results: PARP inhibitor

• Science & Technology
• Health & Medicine

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer. In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

9 September 2017

• Health & Medicine

Targeted drug helps keep some advanced ovarian cancers at bay

Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening. Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.

8 September 2017

• Charity News

Reviewing our year

Read about some of the progress we've made over the last financial year and about some of the big themes from the year. Read about some of the progress we've made over the last financial year and about some of the big themes from the year.

20 July 2017

• Health & Medicine

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer. Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

19 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017

• For Researchers

Honouring a giant of translational research: Stan Kaye

In 2016 we awarded our Lifetime Achievement in Cancer Research Prize to Professor Stan Kaye, who has made exceptional advances in cancer drug development. In 2016 we awarded our Lifetime Achievement in Cancer Research Prize to Professor Stan Kaye, who has made exceptional advances in cancer drug development.

19 May 2017

• Science & Technology

More breast cancer patients than previously thought could benefit from existing targeted treatment

As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates. As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.

13 March 2017

• Health & Medicine

Ovarian cancer drug could target gene fault in brain tumours

A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest. A genetic flaw that’s often found in a type of brain tumour may stop the cells from fixing damage to their DNA, findings from a new US study suggest.

1 February 2017

• For Researchers

Future leaders and a lifetime in drug development: our research prizes

Last week we had the pleasure of awarding our Research Prizes to five exceptional researchers at our annual prizegiving ceremony at the NCRI Conference. Last week we had the pleasure of awarding our Research Prizes to five exceptional researchers at our annual prizegiving ceremony at the NCRI Conference.

16 November 2016

• Personal Stories

How your support is helping us beat breast cancer – Margaret’s story

The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more. The year is 2016, Breast Cancer Awareness Month is upon us, and right now, 8 in 10 women diagnosed with breast cancer will survive their disease for 10 years or more.

1 October 2016

• Science & Technology

CRT and SV Life Sciences form Artios Pharma to focus on DNA damage response

Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma. Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.

21 September 2016

• Health & Medicine

Crashing cancer’s backup system – our progress so far

Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey? Research by our scientists played a major part in the development of a promising new class of cancer drugs. So where are we now in this research journey?

12 September 2016